Nm23 gene expression and cellular growth and differentiation
Nm23基因表达与细胞生长和分化
基本信息
- 批准号:08680778
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The differentiation inhibitory factor /nm23 protein can inhibit the differentiation of murine and human myeloid leukemia cells. Block of differentiation may be associated with the aggressive behavior of leukemia. To examine the role of nm23 in growth and differentiation of human myeloid leukemia cells, we investigated the relative levels of nm23-H1, nm23-H2 and c-myc transcripts in normal blood cells, normal bone marrow cells, leukemic cell lines, and leukemic cells from patients with acute myeloid leukemia (AML) by reverse transcriptase polymerase chain reaction.Expression levels of nm23-H1 and nm23-H2 in leukemic cell lines and the AML samples were significantly higher than that in normal blood cells and a higher level of nm23-H1 expression was correlated with a poor prognosis in AML.An analysis of the correlation between nm23 expression and the clinical parameters demonstrated that increased nm23-H1 mRNA levels were associated with resistance to initial chemotherapy and with reduced overall survival. Multivariate analysis of putative prognostic factors revealed that elevated nm23-H1 mRNA levels significantly contributed to the prognosis of patients with AML,especially in AML-M5.We confirmed the overexpresion of nm23 proteins in leukemic cells by Western blot, immunohistochemical staining, and flow cytometrical analysis. All leukemic cell lines examined expressed nm23-H1 protein on the cell surface, but the normal blood and bone marrow cells did not. These results show that the cell surface expression of nm23 protein is specific for leukemic cells.
分化抑制因子/nm 23蛋白可抑制小鼠和人髓系白血病细胞的分化。分化阻滞可能与白血病的侵袭行为有关。为了检测nm 23在人髓性白血病细胞生长和分化中的作用,我们研究了正常血细胞、正常骨髓细胞、白血病细胞系、逆转录聚合酶链反应检测急性髓系白血病(AML)患者白血病细胞和正常对照细胞中nm 23-H1和nm 23-H2的表达水平。nm 23-H1 mRNA表达水平与AML患者的预后有关,nm 23-H1 mRNA表达水平与AML患者的临床参数相关性分析表明,nm 23-H1 mRNA表达水平升高与初治化疗耐药及总生存期降低有关。多因素分析提示,nm 23-H1 mRNA水平升高与AML患者的预后有关,尤其是AML-M5患者。我们通过Western blot、免疫组化染色和流式细胞术分析证实了nm 23蛋白在白血病细胞中的过度表达。所有白血病细胞系均表达nm 23-H1蛋白,而正常血细胞和骨髓细胞均不表达nm 23-H1蛋白。这些结果表明nm 23蛋白的细胞表面表达对于白血病细胞是特异性的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Wakimoto, N.: "Combined analsis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukemia." Br.J.Cancer. (in press). (1998)
Wakimoto, N.:“分化抑制因子 nm23-H1 和 nm23-H2 作为急性髓系白血病预后因素的联合分析。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Makishima, M.: "Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1α-hydroxyvitamin D derivatives and their …" Br.J.Cancer. 77・1. 33-39 (1998)
Makishima, M.:“1α-羟基维生素 D 衍生物及其……对人单核细胞白血病细胞的生长抑制和分化诱导”Br.J.Cancer 77・1 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yokoyama, A.: "Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies." BLOOD. 91-6. 1845-1851 (1998)
Yokoyama, A.:“通过多变量分析评估分化抑制因子 nm23 作为急性髓性白血病的预后因素及其在其他血液恶性肿瘤中的应用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
角 純子: "分化誘導抑制因子nm23の臨床的意義" 血液・腫瘍科. 36・2. 185-195 (1998)
Junko Kado:“分化诱导抑制剂 nm23 的临床意义”血液学和肿瘤学 36・2(1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Makishima, M.: "Growth inhibition and differentiation induction in human monoblastic leukaemic cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea." Br.J.Cancer. 77-1. 33-39 (1998)
Makishima, M.:“1α-羟基维生素 D 衍生物对人单核细胞白血病细胞的生长抑制和分化诱导作用,以及与羟基脲组合的增强作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKABE Junko其他文献
OKABE Junko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKABE Junko', 18)}}的其他基金
The Subjective and Objective Interface of Bias Detection on language tests
语言测试偏差检测的主客观界面
- 批准号:
15520366 - 财政年份:2003
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
淋巴细胞白血病细胞转录重编程的新策略
- 批准号:
10392174 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
淋巴细胞白血病细胞转录重编程的新策略
- 批准号:
10543999 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Elucidation of the mechanism of steroid-structure anticancer drug resistance to leukemia cells and application to personalized diagnosis
白血病细胞类固醇结构抗癌药物耐药机制的阐明及其在个体化诊断中的应用
- 批准号:
21K07406 - 财政年份:2021
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the interaction effect of PECAM-1 and bone marrow stromal cells on leukemia cells
PECAM-1与骨髓基质细胞对白血病细胞相互作用的分析
- 批准号:
20K17371 - 财政年份:2020
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeting mitochondria metabolism to selectively kill leukemia cells
靶向线粒体代谢选择性杀死白血病细胞
- 批准号:
418562 - 财政年份:2020
- 资助金额:
$ 1.22万 - 项目类别:
Operating Grants
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
人急性白血病细胞E-选择素配体分析及其在白血病发生中的生物学作用
- 批准号:
10441418 - 财政年份:2019
- 资助金额:
$ 1.22万 - 项目类别:
Development and evaluation of biochips for measuring ultraviolet light absorption and fluorescence observation of leukemia cells
白血病细胞紫外光吸收和荧光观察生物芯片的开发与评价
- 批准号:
19K20704 - 财政年份:2019
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
人急性白血病细胞E-选择素配体分析及其在白血病发生中的生物学作用
- 批准号:
10384552 - 财政年份:2019
- 资助金额:
$ 1.22万 - 项目类别:
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
人急性白血病细胞E-选择素配体分析及其在白血病发生中的生物学作用
- 批准号:
10226294 - 财政年份:2019
- 资助金额:
$ 1.22万 - 项目类别:
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
人急性白血病细胞E-选择素配体分析及其在白血病发生中的生物学作用
- 批准号:
10646189 - 财政年份:2019
- 资助金额:
$ 1.22万 - 项目类别: